Nazli Azimi, Pharm.D., PH.D.
Founder & Chief Executive Officer
Dr. Azimi is Bioniz’ founder, co-inventor of its core technology, and has served as the Company’s Chief Executive Officer since its inception. After graduating from the University of Tehran with a doctorate in pharmacy in 1992, Dr. Azimi completed her post-doctoral immunology program at one of the premier research groups at the National Institutes of Health (NIH), directed by Dr. Thomas Waldmann, a pioneer in the field of immune-therapy. During a decade of research at the NIH as a post-doctoral fellow and an independent scientist, Dr. Azimi made seminal contributions to the field of immunology, which later became the foundation for Bioniz’s platform technology. In 2004, Dr. Azimi joined the faculty at the Fred Hutchinson Cancer Research Center, where she studied immune cytokine responses to herpes virus. Prior to founding Bioniz, Dr. Azimi served as founder and CEO of Dermaheal USA, a privately held dermatology company. Dr. Azimi has authored over 30 peer-reviewed, high impact scientific publications and is the inventor of more than a dozen patents, including the Bioniz intellectual property patent estate.